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Objective To investigate whether high estimates of the burden of depression could be attributed to an overestimation of disability 
weights (reﬂecting more severe disability).
Methods We derived disability weights that were tailored to prevalence data. Empirical disability data from a Dutch community 
survey was used to describe three classes of severity of depression and their proportional prevalence. We obtained valuations from 
experts for each class and calculated the overall disability weight for depression.
Findings Expert valuations were similar to those of previous studies. The overall disability weight for depression was similar to other 
studies except the 1994 Dutch Burden of Disease Calculation, which it exceeded by 73%. The lower Dutch 1994 disability weight 
resulted from an overestimation of the proportion of mild cases of depression by experts (60% versus 27% observed in the empirical 
data used in the present study).
Conclusion This study found no indication that disability associated with depression was overestimated. The Dutch example showed 
the importance of tailoring disability weights to epidemiological data on prevalence.
Keywords Depressive disorder, Major; Disability evaluation; Disabled persons/statistics; Cost of illness; Comparative study; Netherlands 
(source: MeSH, NLM).
Mots clés Dépression involutive; Evaluation incapacité; Handicapé/statistique; Coût maladie; Etude comparative; Pays-Bas (source: 
MeSH, INSERM).
Palabras clave Depresión involutiva; Evaluación de la incapacidad; Personas incapacitadas/estadística; Costo de la enfermedad; 
Estudio comparativo; Países Bajos (fuente: DeCS, BIREME).
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Introduction
One of the major ﬁndings of the 1990 global burden of disease 
study was the importance of major depression as a contributor 
to the worldwide disease burden, with an impact exceeding that 
of cerebrovascular disease and cancers (1). The measure of the 
burden of disease used in this study, the disability-adjusted life 
year, combines the number of life-years lost due to premature 
mortality and the number of years lived with disability using a 
set of disease-speciﬁc disability weights. Years lived with depres-
sion were weighted for the severity of the disability associated 
with the disease using depression-speciﬁc disability weights. 
The prominence of major depression as a contributor to disease 
burden was replicated in several national burden of disease 
studies that followed the 1990 study (2–4) and in the 2000 
study (5). This high burden is based on the high prevalence 
ﬁgures for major depression found in community surveys (6–8) 
and the high disability weights derived from expert opinion. 
Although the effects of major depression on functioning and 
well-being are reported to be strong (8–12), the high disability 
weights used in burden-of-disease studies may be questioned 
because much of the empirical information on disability from 
depression comes from clinical cases. Population surveys, on the 
other hand, may include milder cases of depression than those 
found in clinical settings (13). Because prevalence estimates are 
derived from general population surveys, the disability weights 
may, consequently, be too high. The burden of major depres-
sion relies heavily on these estimates, as the mortality compo-
nent is low (1–5).
The aim of our study was to investigate whether the 
burden of depression has been overestimated because disability 
weights have been inaccurately tailored to the prevalence data. 
We used information on disability taken from a community 
survey as reported by people with depression. Disability was 
deﬁned as limitations in the physical, psychological and social 
domains of functioning. Previously, we distinguished three clus-
ters of severity of major depression: mild, moderate to severe, 
and severe with psychotic features (14). We derived empirical 
disability weights for these three classes of severity and com-
bined them with their empirical prevalence estimates into an 
overall disability weight for major depression.
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Box 1. Example of disease-stage description for depression
Depression
Depression is divided into the following stages:
1. mild
2. moderate to severe
3. severe with psychotic features.
We now ask you to value:
Patients with moderate to severe depression
These people experience one or more depressive episodes within a 
year. During these periods they go through permanent feelings of 
sadness or emptiness and a permanent loss of interest or pleasure in 
nearly all activities. They have problems eating and/or sleeping and 
feel worthless or guilty. They may have thoughts of death.
In a year in which one or more episodes are experienced, their 
condition is such that they have:
•  no problems in walking about
•  no problems with self-care
•  some problems with performing usual activities (e.g. work, study,  
housework, family or leisure activities)
•  moderate pain or discomfort (feeling tired)
•  moderate anxiety or depression
•  some cognitive impairments (with memory, concentration, disorga-
nization, IQ level)
Methods
The study was divided into four parts:
1. a valuation study to derive disability weights for the three 
classes of severity;
2. a comparison of the results with a previous valuation study;
3. the calculation of an overall disability weight for major 
depression;
4. comparison of the overall disability weight to previous 
estimates of disability weights for major depression.
Valuation study
Disease selection, staging and description
We included four other disorders in the valuation study to pre-
vent bias. The disorders we asked experts to value were: major 
depression, obsessive–compulsive disorder, oesophageal cancer, 
prostate cancer, and vision disorders. Each disease was subdi-
vided into different stages that were assumed to represent a 
homogeneous group of people in terms of disability, treatment 
and prognosis. In total 18 disease-stages were valued: the three 
severity classes of major depression, three stages for oesophageal 
cancer, two for obsessive–compulsive disorder, and ﬁve for each 
of the other two disorders.
A lay-accessible version of the text and a standardized 
functional health status description were provided for each 
disease stage. An example of the lay text and the standardized 
functional health status description are shown in Box 1. We 
used a health classiﬁcation system adapted from the original 
EuroQol 5D-3L classiﬁcation and refer to it as EuroQol 
5D+C5L (15, 16). It includes cognition as a sixth dimension 
of health (5D+C) along with mobility, self-care, usual activities, 
pain/discomfort, and anxiety/depression. We have adapted the 
three levels to a ﬁve-level scale (5L): in this scheme the ﬁrst, 
third and ﬁfth levels are identical to those in EuroQol 5D-3L 
but we have added two intermediate levels.
For major depression we based the information in the 
lay text on the criteria for major depression and its severity 
as deﬁned by the Diagnostic and statistical manual of mental 
disorders, third edition, revised (DSM-III-R). The EuroQol 
description was based on data from the Netherlands Mental 
Health Survey and Incidence Study (NEMESIS) (9, 14). The 
eight scales of the Short Form-36 health survey (17) were used 
as indicators of disability along with two additional questions. 
These questions asked about the number of days spent in bed 
due to psychiatric problems, drug-related problems or alcohol-
related problems, and the number of days someone was unable 
to work due to these problems. We used a formal algorithm 
(available from the authors on request) to map these disability 
data onto the EuroQoL 5D+C5L classiﬁcation.
For comparative purposes, the descriptions of obsessive–
compulsive disorder and oesophageal cancer were the same as 
those used in a previous study, the Dutch disability weights 
study (18). We re-coded the associated EuroQol 5D+C3L 
descriptions into the 5D+C5L instrument. Descriptions and 
resulting values for prostate cancer and vision disorders will 
be presented elsewhere.
Valuation procedure and respondents
The valuation procedure was largely the same as that used in 
the Dutch disability weights study (18). In brief, we recruited 
medical doctors assumed to have sufﬁcient knowledge of the 
consequences of a broad range of diseases. A convenience 
sample of 75 doctors was contacted by postal questionnaire; 55 
of these doctors had previously participated in similar studies 
(18, 19).
We replicated the Dutch disability weights study’s inter-
polation procedure in which respondents were asked to place 
(or interpolate) disease stages on a disability scale. This scale 
ranged from 0 (worst imaginable health state) to 100 (best 
imaginable health state) and was formally calibrated in the ear-
lier study with person trade-off derived disability weights for 16 
conditions. We replaced the conditions “mild major depression” 
and “severe vision disorder” on the original scale with disorders 
that had comparable disability weights (mild to moderate panic 
disorder and grade 3–4 arthritis).
The duration of a disease stage to be valued was deﬁned 
as one year for all diseases.
Analyses of the interpolation data
For each disease-stage, we calculated the disability weight as: 
1 – mean value/100. We examined the validity and reliability 
of the valuations by checking compliance with a pre-imposed 
order of stages of mental disorders (mild, moderate, severe); 
inspecting the Spearman rank correlation among respondents; 
and estimating the proportion of total variance that was at-
tributable to the disease stages, using generalizability theory 
(G-study) (20, 21).
We also studied associations of age, sex, current profes-
sion (GP, psychiatrist, researcher, other) and having medical 
experience (< 1 year versus > 1 year) with the valuations in a 
regression analysis. All analyses were performed in SAS ver-
sion 6.12 (22).
Comparison with the Dutch disability weights study
We compared disability weights for stages of major depression 
from the present study with those from the earlier study (18). 
In this study mild and severe depression were valued separately. 
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Because respondents to the two studies were not drawn from 
independent studies, standard statistical testing was not 
used. Instead, we compared the 95% conﬁdence intervals. 
The disability weights for obsessive–compulsive disorder 
and oesophageal cancer from both studies were compared 
to estimate test–retest reliability.
Overall disability weight
We calculated an overall disability weight for major depression 
by combining the disability weights for each of the three classes 
of severity with their proportional prevalence. Prevalence data 
for the three classes were obtained from the NEMESIS study. 
We distributed proportionally the residual prevalence of cases 
with “unspeciﬁed severity” across the classes, excluding the class 
severe depression with psychotic features because we assumed 
psychotic features were unlikely to be missed. 
Comparison with previous estimates
We compared the overall disability weight from the present 
study with overall disability weights from four studies: the 
Dutch national burden of disease calculation for 1994 (3), the 
1990 global burden of disease study (1), the Australian Burden 
of Disease Study (2), and another Australian study by Andrews 
et al. (23, 24). Both the Dutch and Australian Burden of Dis-
ease studies used the same severity-speciﬁc disability weights 
from the Dutch disability weights study (18) to calculate an 
overall disability weight, but they used different methods to 
obtain proportional distributions of the classes of severity.
Results
Description of classes of severity
The lay texts and functional health status descriptions for the 
three classes of severity of major depression are shown in Table 1 
(web version only, available at: http://www.who.int/bulletin).
Respondents
A total of 49 medical doctors participated (24 men, 25 women; 
65% response rate). Respondents had a mean age of 46.6 years 
(standard deviation = 8.8). On average respondents had 12.2 
years of medical experience. A total of 53% of respondents 
were involved directly in patient care (14 general practitioners, 
5 psychiatrists and 7 in other types of care); 35% worked in 
medical research and 12% worked in other health-related pro-
fessions or were retired.
Analyses
Table 2 and Table 3 show the disability weights with their 95% 
conﬁdence intervals for the three severity classes of depression. 
All respondents but one complied with the ranking implied 
by the severity-speciﬁc classes of psychiatric disorders (mild, 
moderate to severe, severe depression with psychotic features). 
Respondents largely agreed with each other on the ranking of 
the 18 disease stages: the mean Spearman correlation coefﬁcient 
was 0.83.
In the generalizability study, 76% of total variance was ex-
plained by the disease stages. Respondents contributed another 
6%, while a residual 18% remained unexplained. Regression 
analyses showed that the variables age, sex, current profession, 
and not having practical medical experience could not signiﬁ-
cantly predict the disability weights of the 18 disease stages.
Comparison with the Dutch disability weights study
Table 2 also provides the disability weights for major depres-
sion obtained in the earlier Dutch study. Disability weights in 
the present study fell within the range of the 95% conﬁdence 
intervals from the earlier study, and for moderate to severe 
depression they fell between the 95% conﬁdence intervals of 
the separately valued classes of severity. EuroQol descriptions 
in the present study were generally less severe.
Table 2 also shows the disability weights for obsessive–
compulsive disorder and cancer of the oesophagus. Re-valuation 
of their stages in the present study resulted in average values 
that fell within the 95% conﬁdence intervals of the disability 
weights from the earlier Dutch study, except in the case of 
severe obsessive–compulsive disorder (present study 0.76, 95% 
conﬁdence interval (CI) = 0.71–0.82 versus earlier study 0.56, 
95% CI = 0.38–0.74).
For depression, the differences between the disability 
weights in the earlier study and those in this study did not 
appear to be larger than those for the two identically described 
conditions. The new disability weights fell within the earlier 
study’s 95% conﬁdence intervals, and the absolute differences 
in the disability weights between the two studies (0.01 and 
0.05) were smaller than for the identically described diseases 
(between 0.01 to 0.20).
Overall disability weight
Table 3 shows how we combined the disability weights for each 
stage of major depression with the prevalence distribution of 
depressive cases across the severity classes to come up with an 
overall disability weight of 0.46.
Comparison to previous estimates
In Table 4 (web version only, available at: http://www.who.
int/bulletin) we compare the overall disability weight for 
depression to that from other studies. The estimate from the 
present study is similar to that of the 1990 global burden of 
disease study (disability weight = 0.47) (1) and close to those 
from the two Australian studies (approximately 0.41 in both 
studies) (2, 22–24). However, it is 73% higher than the one 
used in the 1994 Dutch national burden of disease calculation 
(disability weight = 0.27) (3). The lower 1994 disability weight 
results from the use of different proportional prevalences of 
severity classes to calculate the overall disability weight. For 
the 1994 calculation these proportional prevalences were 
based on expert opinion, while in the present study data from 
NEMESIS were used. Experts estimated that 60% of cases 
had mild major depression, 30% had moderate disease, 9% 
had severe disease and 1% had severe disease with psychotic 
features; in the NEMESIS study only 27% of cases had mild 
major depression (Table 3). The lower overall disability weight 
in the 1994 study is not caused by different valuations: the 
disability weights for the separate severity classes were similar 
between the two studies.
Discussion
We derived disability weights for major depression occurring 
in a community setting by using prevalence and disability data 
from the Dutch community-based survey known as NEMESIS. 
The overall disability weight for major depression was similar 
to or higher than that used in several burden of disease studies 
(1–3, 23). This indicates that disability weights used in previous 
calculations of the burden of depression were not too high.
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Table 3. Disability weight for severity classes of major depression and calculation of the average disability weight 
Severity of depression EuroQol 5D+C5La % of prevalenceb Disability weight 95% CId
Mild 112222 26.7c 0.19 0.16–0.22
Moderate to severe 113333 61.9c 0.51 0.46–0.55
Severe with psychotic features 214444 11.4 0.84 0.80–0.88
Total   100 0.46
a  The six digits in this column correspond to scores on the six dimensions of the EuroQol 5D+C5L scale. These dimensions are mobility, self-care, usual activities,  
 pain/discomfort, anxiety/depression, and cognition. A score of 1 indicates that a person has no problems functioning in that dimension; a score of 2 indicates  
 that a person has a few problems functioning; a score of 3 indicates that a person has some or moderate problems; a score of 4 indicates there are severe  
 problems; and a score of 5 indicates there are very severe problems or an inability to function. 
b  Prevalence data obtained from the Netherlands Mental Health Study and Incidence Survey (NEMESIS) (7, 14).
c  Prevalence includes major depression of unspeciﬁed severity.
d  CI = conﬁdence interval.
The disability weights for the separate classes of severity 
of depression did not deviate greatly from the Dutch disability 
weights study (18). In that study, descriptions of functional 
health status (using EuroQol) were based on case deﬁnitions 
and expert opinion and were not tailored to the community 
setting. On average these descriptions were somewhat more 
severe than the ones in the present study (which were based on 
self-reported disability from NEMESIS), and we expected our 
disability weights for different stages of depression to be lower 
(i.e. indicating less disability) than in the earlier study. Never-
theless, the differences between the disability weights in the 
two studies did not appear to be signiﬁcant. Similar disability 
weights for different stages of major depression were also found 
in an Australian study (24). As has been suggested before (25), 
the health status descriptions in EuroQol may have only a small 
effect on valuation. Apparently the label provided (disease and 
severity class) is much more important to evaluators.
The overall disability weight (i.e. the combination of 
stage-speciﬁc disability weights and prevalence) from the pres-
ent study was similar to that used in the 1990 global burden of 
disease study and two Australian studies (1, 2, 23). Thus there 
is no reason to suspect that the disability weights were overes-
timated previously. Therefore, the high burden of depression 
estimated by the 1990 study and by several national studies 
does not appear to have been exaggerated by overestimation 
of disability weights.
On the contrary, the burden of depression seems to have 
been underestimated in the 1994 Dutch national burden of 
disease calculation (3): the disability weight in the present study 
was 73% higher than the weight used in the 1994 calculation. 
In the 1994 study experts estimated that a larger proportion of 
people had mild depression than was observed in NEMESIS. 
These prevalence data on the distribution of disability associ-
ated with major depression had a major impact on the overall 
disability weight (and burden). This shows the importance of 
using quantitative epidemiological information in burden of 
disease calculations. The calculation of the overall disability 
weight using the proportional distribution of the classes of 
severity enabled us to better tailor the disability weight to the 
community setting. It also pointed out the previous underes-
timation of the burden of major depression in the Netherlands 
and the importance of the epidemiological data.
Conclusions
Our study found no indication that previously estimated dis-
ability weights were overestimates because they had not been 
tailored to the community setting. Our tailored disability 
weights were similar to those found in most other studies, 
including the global burden of disease study, and do not decrease 
the estimated burden of depression. These results reinforce the 
validity of previous high estimates of the burden of depression. 
This study additionally points out the importance of obtaining 
sound epidemiological data in burden of disease studies.  O
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Résumé
La charge de dépression a-t-elle été surestimée
Objectif Examiner la possibilité d’attribuer la valeur élevée 
des estimations de la charge de dépression à une surestimation 
des coefﬁcients de pondération servant au calcul des années 
d’incapacité (indiquant une degré plus grave d’incapacité).
Méthodes Des coefﬁcients de pondération destinés au calcul des 
années d’incapacité et adaptés aux données de prévalence ont 
été établis. Les données d’incapacité empiriques provenant d’une 
enquête néerlandaise en communauté ont servi à décrire trois 
classes de gravité de la dépression et leurs taux de prévalence. 
Des évaluations des coefﬁcients de pondération pour chacune 
des classes ont été obtenu auprès d’experts, ce qui a permis de 
déterminer le coefﬁcient de pondération global pour le calcul des 
années d’incapacité associées à la dépression.
Résultats Les évaluations établies par les experts étaient 
similaires à celles fournies par les études antérieures. Dans le 
cas de la dépression, le coefﬁcient de pondération global pour le 
calcul des années d’incapacité présentait une valeur analogue à 
celle obtenue dans les autres études, à l’exception du Calcul de 
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Resumen
¿Se ha sobrestimado la carga de depresión?
Objetivo Investigar si las altas estimaciones de la carga de 
depresión podrían atribuirse a una sobrestimación de las 
ponderaciones de la discapacidad (que reﬂejarían una mayor 
gravedad de ésta).
Métodos Desarrollamos ponderaciones de la discapacidad 
ajustadas a los datos de prevalencia. Se usaron los datos empíricos 
de discapacidad de una encuesta llevada a cabo en una comunidad 
holandesa para describir tres clases de gravedad de la depresión y 
su prevalencia proporcional. Obtuvimos valoraciones de los expertos 
para cada clase y calculamos el peso global de la discapacidad 
por depresión.
Resultados Las valoraciones de los expertos fueron similares 
a las de estudios anteriores. El peso global de la discapacidad 
correspondiente a la depresión fue similar al de otros estudios, 
exceptuando el del Cálculo de la Carga de Morbilidad de los 
Países Bajos de 1994, que superó en un 73%. El menor peso de 
la discapacidad obtenido en el estudio holandés de 1994 se debió 
a que los expertos sobrestimaron la proporción de casos leves de 
depresión (60%, frente al 27% observado en los datos empíricos 
usados en el presente trabajo).
Conclusión Este estudio no ha detectado ningún indicio de que 
se haya sobrestimado la discapacidad asociada a la depresión. 
El ejemplo holandés muestra la importancia de ajustar las 
ponderaciones de la discapacidad a los datos epidemiológicos 
sobre la prevalencia.
la charge de morbidité au Pays-Bas de 1994, qui aboutissait à 
un chiffre inférieur de 73 %. Le coefﬁcient de pondération plus 
faible de l’étude néerlandaise résultait d’une surestimation par 
les experts de la proportion de cas de dépression sans gravité 
(60 % contre 27 % d’après les données empiriques utilisées dans 
la présente étude).
Conclusion Cette étude n’a mis en évidence aucun élément 
indiquant une surestimation de l’incapacité liée à la dépression. 
L’exemple néerlandais montre l’importance d’une adaptation des 
coefﬁcients pondéraux servant au calcul des années d’incapacité 
aux données épidémiologiques de prévalence.
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Table 1. Three severity classes (stages) of major depression used in this study
 EuroQol 5D+C5L dimensionb
Severity Lay descriptiona Mobility Self- Usual Pain/ Anxiety/ Cognition 
   care activities discomfort depression
Mild These people experience one or more  1  1 2 2 2 2 
 depressive episodes within a year. During  
 these periods they have permanent feelings 
 of sadness or emptiness or a permanent loss 
 of interest or pleasure in nearly all activities.  
 They may have problems eating or sleeping  
 and can feel worthless or guilty. They may  
 have thoughts of death.
Moderate  These people experience one or more 1 1 3 3 3 3 
to severe depressive episodes within a year. During  
 these periods they have permanent feelings  
 of sadness or emptiness and a permanent  
 loss of interest or pleasure in nearly all  
 activities. They have problems eating and/or  
 sleeping and feel worthless or guilty. They  
 may have thoughts of death.
Severe  These people experience one or more  2 1 4 4 4 4 
with  depressive episodes within a year. During 
psychotic  these periods they have permanent feelings  
features of sadness or emptiness and a permanent loss  
 of interest or pleasure in nearly all activities.  
 Furthermore, they experience delusions and  
 hallucinations. They have problems eating  
 and sleeping and feel worthless or guilty.  
 They have thoughts of death.
a  Descriptions are translated from Dutch. Lay descriptions were based on DSM-III-R criteria for major depression and severity.
b  The six digits in this column correspond to scores on the six dimensions of the EuroQol 5D+C scale. On the EuroQol 5D+C5L scale a score of 1 indicates that a  
 person has no problems functioning; a score of 2 indicates that a person has a few problems functioning; a score of 3 indicates that a person has some or  
 moderate problems; a score of 4 indicates there are severe problems; and a score of 5 indicates there are very severe problems or an inability to function. EuroQol  
 scores were based on disability indicators from Dutch population surveys (7, 14).
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Table 2. Disability weights obtained in the present study compared with those obtained in the Dutch disability weights study (18) 
 Current study Dutch disability weights study
Disease and stage EuroQol  Disability 95% CIc EuroQol Disability 95% CI 
 scorea, b weight  scorea weight
Major depression  
Mild 112222 0.19 0.16–0.22 113131 0.14 0.09–0.19
Moderate to severe 113333 0.51 0.46–0.55   
Moderate    133133 0.35 0.27–0.42
Severe    335353 0.76 0.56–0.97
Severe with psychotic features 214444 0.84 0.80–0.88 335355 0.83 0.75–0.92
Cancer of the oesophagus      
Diagnosis and primary therapy  112441 0.52 0.48–0.57 112441d 0.53 0.36–0.70
After intentionally curative primary therapy 113331 0.42 0.37–0.46 113331 0.38 0.25–0.51
Irradically removed/disseminated carcinoma 114451 0.82 0.79–0.84 114451d 0.73 0.61–0.86
Obsessive–compulsive disorder      
Mild to moderate 113133 0.30 0.26–0.33 113133 0.24 0.17–0.32
Severe 133155 0.76 0.71–0.82 133155 0.56 0.38–0.74
a  The six digits in this column correspond to scores on the six dimensions of the EuroQol 5D+C5L scale. These dimensions are mobility, self-care, usual activities,  
 pain/discomfort, anxiety/depression, and cognition. A score of 1 indicates that a person has no problems functioning in that dimension; a score of 2 indicates that  
 a person has a few problems functioning; a score of 3 indicates that a person has some or moderate problems; a score of 4 indicates there are severe problems;  
 and a score of 5 indicates there are very severe problems or an inability to function. 
b  These EuroQol scores were based on disability indicators from Dutch population surveys (7, 14).
c  CI = conﬁdence interval.
d  For these stages the Dutch disability weights study gave two EuroQol 5D+C3L descriptions, each having a 50% possibility of occurring. We re-coded these into  
 EuroQol 5D+C5L levels by averaging the two descriptions, thereby using the two additional levels (level 2 and 4) of this system.
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Table 4. Comparison of overall disability weights for depression from different studies
Studya  Method of deriving Severity classes Distribution Overall disability 
 disability weight  across classes weight
Present study  Interpolation on a Mild; Dutch survey datab 0.459 
(the Netherlands) person trade-off  moderate to severe; 
 calibrated disability scale severe with psychotic features
1990 global burden  Person trade-off Treated versus Expert estimation 0.469 
of disease study (1)   Untreated 
(established market  
economies)
Dutch national burden  Dutch disability weights  Mild; Expert estimation 0.266 
of disease calculation (3) study: person trade-off  moderate; 
(the Netherlands) and interpolation on a  severe; 
 person trade-off  severe with psychotic features 
 calibrated disability scale
Australian Burden Dutch disability weights Mild; Short Form-12 health 0.41 (m) 0.37 (f) 
of Disease Study (2) study: person trade-off moderate; survey cut-off scores 
(Australia) and interpolation  severe  in Australian surveyc
Andrews et al. (23, 24)  Person trade-off Mild episode; Short Form-12 cut-off  0.417 
(Australia)   moderate episode;  scores in Australian 
  severe episode surveyc
a  Information in parentheses indicates where study took place. 
b  Data were derived from the Netherlands Mental Health Study and Incidence Survey (NEMESIS) (7, 14).
c  Data collected during the Australian National Mental Health and Wellbeing Survey (8).
